Table 3.

Associations between BMI1, PTEN, PHLPP1 and PHLPP2 mRNAs expression and clinicopathological data

Clinicopathological parameter	BMI‐1		PTEN		PHLPP1		PHLPP2
	Mean ± SD	P‐value	Mean ± SD	P‐value	Mean ± SD	P‐value	Mean ± SD	P‐value
Normal	1760 ± 156	.08	8941 ± 1319	.051	7279 ± 1257	.135	885.0 ± 189.9	.039
Cancer	2504 ± 272		11 681 ± 2557		5803 ± 690.3		526.4 ± 76.33
Grade
1	1702 ± 179	.065	7011 ± 1865	.013 a	5946 ± 1392	.807	540.3 ± 186.6	.509
2	3050 ± 106		12 514 ± 3106		6198 ± 1005		538.6 ± 106.3
3	3920 ± 350		3465 ± 843.3		4520 ± 951.3		478.5 ± 118.5
Stage
I	3076 ± 450	.09	7632 ± 1124	.012 b	6951 ± 1002	.091	602.4 ± 108.9	.284
II	2750 ± 206		2820 ± 645.5		3873 ± 851.7		317.8 ± 62.4
III + IV	2078 ± 388		5458 ± 1523		4784 ± 1592		557.2 ± 213.4
Lymph node metastasis
No	2432 ± 276	.046	11 400 ± 2775	.905	5862 ± 738.0	.425	507.2 ± 77.7	.950
Yes	1690 ± 305		6554 ± 1949		5474 ± 2003		633.1 ± 262.2

Kruskal‐Wallis test was used to compare more than two groups. For pairwise multiple comparisons the Dunn's post hoc test was used.

Bold and italic values show statistically significant differences.

^a2 vs 3.

^bI vs II.